Frequency and affecting factors of metabolic syndrome in women older than 20 years of age;Yirmi yaş ve üzeri kadinlarda metabolik sendrom sikliǧi ve bunu etkileyen faktörler

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 2, 2010, Pages 111-119

  Kitiş, Yeter ^a   Bilgili, Naile ^a   Hisar, Filiz ^a   Ayaz, Sultan ^a  

^a UNIVERSITY OF HEALTH SCIENCES   (Turkey)

Author keywords

Logistic regression analysis; Metabolic syndrome; Prevalence; Risk factors; Women

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; AGE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FEMALE; HEALTH CENTER; HIGH RISK POPULATION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; URBAN AREA; WOMEN'S HEALTH; ANALYSIS OF VARIANCE; BLOOD; MIDDLE AGED; PREVALENCE; STATISTICAL MODEL;

ADULT; ANALYSIS OF VARIANCE; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 77952535677     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.033     Document Type: Article

References (46)

1. Grundy SM, Brewer BH, Cleeman JI, Smith SC, Lenfant C. Definition of Metabolic Syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. NHLBI/AHA Conference Proceedings. Circulation 2004; 109: 433-8.
2. American Hearth Association. Treatment Panel III; Final Report on Detection. Evaluation. And Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel. Circulation 2002; 106: 3143-421.
3. Korkmaz A, Topal T. Modern yaşam tarzi ve yeni hastaliklar: Metabolik sendrom örneǧi. TSK Koruyucu Hekimlik Bülteni 2006; 5: 307-16.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on the Detection. Diagnosis and Treatment of High Cholesterol in Adults: (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
5. Ludwig DS. Clinician's corner the glycemic index physiological mechanism metabolic syndrome relating to obesity. Diabetes and cardiovascular disease. JAMA 2002; 287: 2414-23.
6. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. World Health Organ. Tech. Rep. Ser 2000; 894: 1-253.
7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults; findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
8. Mokdad HA, Ford ES, Bowman BA, Dietz WH, Winicor F, Bales VS, et al. Prevalence of obesity. Diabetes and obesity- related health risk factors 2001. JAMA 2003; 289: 76-9.
9. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
10. Türk Kardiyoloji Dernegi. METSAR "Türkiye Metabolik Sendrom Araştirmasi". 21. Ulusal Kardiyoloji Kongresi; 2005 16-20 Kasim: Antalya, Türkiye.
11. Onat A, Sansoy V. Halkimizda koroner hastaliǧin başsuçlusu metabolik sendrom: Sikliǧi, unsurlari, koroner risk ile ilişkisi ve yüksek risk bileşenleri. Türk Kardiyol Dern Arşivi 2002; 30: 8-15.
12. Soysal A, Demiral Y, Soysal D, Uçku R, Köseoǧlu M, Aksakoǧlu G. The prevalence of metabolic syndrome among young adults in Izmir, Turkey. Anadolu Kardiyol Derg 2005; 5: 196-201.
13. Gökçel A, Özsahin AK, Sezgin N, Akbaba M, Güvener D, Özişik L. Güney Kenti Adana'da Metabolik Sendrom prevalansi. TJEM 2003; 7: 1-8.
14. Onat A, Uyarel H, Karabulut, Albayrak S, Doǧan Y, Can G, et al. Halkimizda abdominal obezitede risk faktörü kümelemeleri ve demografik daǧilim. Türk Kardiyol Dern Arş 2005; 33: 195-203.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary. Circulation 2005; 112: 2735-52.
16. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin N Am 2004; 33: 351-75.
17. Türk Kardiyoloji Derneǧi. Ülkemizde kalp-damar hastaliklarinin epidemiyolojisi ile ilgili gerçekler. Ulusal Kalp Saǧliǧi Politikasi Ana Ilkeleri. 2007: 58. Available from: URL: http://www.tkd-online.org/ UKSP/UKSP_Bolum02.pdf.
18. Bonora ES, Kiechl, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, et al. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes 2003; 27: 1283-9.
19. Park HS, Park CY, Oh SW, Yoo HJ. National prevalence of obesity and metabolic syndrome in Korean adults. Obes Rev 2007; 9: 104-7.
20. Surgeon General. The health consequences of smoking: A report of the Surgeon General. Atlanta. GA: Center for Disease Control and Prevention. Office of Smoking and Health. Available from: URL: http:// www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/chapters.htm.
21. Miyatake N, Wada J, Kawasaki Y, Nishii K, Makino H, Numata T. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med 2006;45: 1039-43.
22. McCoulay KM. Modifying women's risk for cardiovascular disease. JOGNN 2007; 36: 116-24.
23. Mutlu FS, Ayranci U, Ozdamar K. Cigarette smoking habits among men and women in Turkey: a meta regression analysis. Iranian J Publ Health 2006; 35: 7-15.
24. Chen CC, Li TC, Chang PC, Liu CS, Lin WY, Wu MT, et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism 2008; 57: 544-8.
25. Onat A, Ceyhan K, Basar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: prospective and cross-sectional evaluation. Atherosclerosis 2002; 165: 285-92.
26. Hill JO, Melanson EL, Overview of the determinants of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc 1999; 3: 515-21.
27. Li TY, Rana JS, Manson JE, Willett WC, Stampfer MF, Colditz GA, et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006; 113: 499-506.
28. Ford ES, Kohl HW, Mokdad AH, Ajani UA. Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults. Obes Res2005; 13: 608-15.
29. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007; 17: 319-26.
30. Delibaşi T, Karaaslan Y, Üstün I, Köroǧlu E, Hoşgör Ş. National prevalence of underweight, overweight and obesity in Turkey: cross sectional study of a representative adult population. CEJM 2007; 2: 294-303.
31. Sanisoǧlu SY, Öktenli C, Haşimi A, Yokuşoǧlu M. Uǧurlu M. Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health 2006; 6: 1-6.
32. Erem C, Arslan C, Hacihasanoglu A, Deǧer O, Topbaş M, Ukinc KI, et al. Prevalence of obesity and associated risk factors in a Turkish population (Trabzon City, Turkey). Obes Res 2004; 12: 1117-27.
33. Yumuk VD, Hatemi H, Tarkçi T, Uyar N, Turan N, Bagriaçik N, et al. High prevalence of obesity and diabetes mellitus in Konya. A Central Anatolian City in Turkey. Diabetes Res Clin Prac 2006; 70: 151-8.
34. Hatemi H, Yumuk VD, Turan N, Arik N. Prevalence of overweight and obesity in Turkey. Metab Syndr Relat Disord 2003; 1: 285-90.
35. Onat A, Avci S, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes 2004; 28: 1018-25.
36. Varlibaş F, Gencer M, Örken C, Çakal N, Tireli H. Metabolic syndrome in cerebrovascular diseases. J Neurol Sci [Türk] 2006; 23: 93-101.
37. Mahley RW, Mahley LL, Bersot TP, Pepin GM, Palaoǧlu KE. The Turkish lipid problem: low levels of high density lipoproteins. TJEM 2002; 1: 1-12.
38. Bersot TP, Pépin GM, Mahley RW. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J 2003; 146: 1052-9.
39. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation and prevention) and the council on nutrition, physical activity and metabolism (subcommittee on physical activity). Circulation 2003; 107: 3109-16.
40. Li CL, Liu FH, Lin JD. Protective effect of physical activity independent of obesity on metabolic risk factors. Int J Sport Nutr Exerc Metab 2006; 16: 255-69.
41. Whelton S, Chin A, Xue X, He J. Effect of aerobic exercise on blood pressure: A meta-analysis of randomized controlled trials. Ann Int Med 2002; 136: 493-503.
42. Rockhill B, Willett W, Manson J, Leitzman M, Stampfer M, Hunter D, et al. Physical activity and mortality: a prospective study among women. Am J Public Health 2001; 91: 578-83.
43. Jakicic JM, Clark K, Coleman E, Donnelly LE, Foreyt J, Volek J, et al. American College of Sports Medicine. American College of Sports Medicine Position Stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2001; 33: 2145-56.
44. Brook RD, Bard RL, Glazewski L, Kehrer C, Bodary PF, Eitzman DL, et al. Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. Am J Cardiol 2004; 93: 1012-6.
45. Zhu S, St-Onge MP, Heshka S, Heymsfield SB. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism 2004; 53: 1503-11.
46. Frank LL, Sorensen BE, Yasui Y, Tworoger SS, Schwartz RS, Ulrich CM, et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res 2005; 13: 615-25.